![Philip Gotwals](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 65 999 $ in data 31/07/2026
Philip J.
Gotwals is currently an Independent Director at Capricor Therapeutics, Inc. since 2023 and an Independent Director at OmniAb, Inc. starting in 2025.
Formerly, Dr. Gotwals was Vice President-Business Development & Licensing at Novartis Institutes for Biomedical Research, Inc. from 2019 to 2023, Vice President-Program Management at Altus Pharmaceuticals, Inc. from 2006 to 2009, and Senior Director-Early Development at Biogen, Inc. from 2004 to 2006.
Education includes undergraduate studies at Amherst College and a doctorate from the University of California, Berkeley.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
OMNIAB, INC. 0,02% | 17/06/2026 | 33.333 ( 0,02% ) | 65 999 $ | 31/07/2026 |
| 28/02/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 21/07/2023 |
| OMNIAB, INC. | Direttore/Membro del Consiglio | 18/04/2025 |
| Società | Posizione | Fine |
|---|---|---|
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | 01/10/2023 |
Altus Pharmaceuticals, Inc.
 Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapeutic products for gastrointestinal and metabolic diseases | Corporate Officer/Principal | 01/01/2009 |
| BIOGEN INC. | Corporate Officer/Principal | 01/09/2006 |
Redsky Partners LLC
 Redsky Partners LLC Financial ConglomeratesFinance RedSky invests long/short with a growth bias without regard to market capitalization. | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Redsky Partners LLC
Redsky Partners LLC Financial ConglomeratesFinance RedSky invests long/short with a growth bias without regard to market capitalization. | Finance |
Amherst College
 Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapeutic products for gastrointestinal and metabolic diseases | Health Technology |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
Capricor Therapeutics, Inc.
 Capricor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative products for the treatment of cardiovascular diseases | Health Technology |
OmniAb, Inc.
 OmniAb, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
